An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine
IJMS | Free Full-Text | Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
Interferons Research Area: R&D Systems
Interferon type I - Wikipedia
Frontiers | Evasion of interferon-mediated immune response by arteriviruses
Relevance of placental type I interferon beta regulation for pregnancy success | Cellular & Molecular Immunology
Immune response - IFN alpha/beta signaling pathway Pathway Map - PrimePCR | Life Science | Bio-Rad
Defining Emerging Roles for NF-κB in Antivirus Responses: Revisiting the Interferon-β Enhanceosome Paradigm | PLOS Pathogens
Type I interferon induction and signaling during SARS-CoV-2 infection (WP4868) - Homo sapiens | WikiPathways
Interferons Research Area: R&D Systems
-Role of IFN secretion during HIV-1 infection. The presence of HIV RNA... | Download Scientific Diagram
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram
The Overview of Interferon-CUSABIO
Decoding type I and III interferon signalling during viral infection | Nature Microbiology
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway | SpringerLink
The Overview of Interferon-CUSABIO
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways: Cell
GeneCopoeia: IFN alpha signaling pathway
How cancer cells make and respond to interferon-I: Trends in Cancer
Anti-Human IFN-Beta, Clone MMHB-1 (MAb) | PBL Assay Science
